Biotech Values

[mcbio]

BIOD - Linjeta sublingual delivery

http://files.shareholder.com/downloads/BIOD/1498076037x0x489721/D9A67A5F-7F55-49E4-B868-7C587E6F7938/Sublingual_Administration_of_Ultra-rapid-acting_Insulin.pdf

I've never heard BIOD mention this before but just saw on BIOD's YMB where a poster linked to this poster presentation from earlier this year showing the possibility of a new sublingual formulation of Linjeta. This would presumably get around the injection-site tolerability issues that Linjeta experienced before with the hope of maintaining the same fast-acting onset. I have no idea how feasible this project is and, again, I don't recall BIOD management mentioning this before but perhaps this is another option down the road beyond their insulin analog program.